Nisa Investment Advisors
IMVT icon

Nisa Investment Advisors’s Immunovant IMVT Stock Holding History

Nisa Investment Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
4,307
+230
+6% +$7.01K ﹤0.01% 1320
2026
Q1 		$101K Buy
4,077
+19
+0.5% +$492 ﹤0.01% 1420
2025
Q4 		$103K Hold
4,058
– – ﹤0.01% 1426
2025
Q3 		$65.4K Buy
4,058
+92
+2% +$1.49K ﹤0.01% 1555
2025
Q2 		$63.5K Sell
3,966
-60
-1% -$907 ﹤0.01% 1532
2025
Q1 		$68.8K Buy
4,026
+17
+0.4% +$356 ﹤0.01% 1494
2024
Q4 		$99.3K Buy
4,009
+127
+3% +$3.6K ﹤0.01% 1475
2024
Q3 		$111K Buy
3,882
+44
+1% +$1.3K ﹤0.01% 1419
2024
Q2 		$101K Buy
3,838
+41
+1% +$1.17K ﹤0.01% 1475
2024
Q1 		$123K Buy
3,797
+38
+1% +$1.39K ﹤0.01% 1414
2023
Q4 		$158K Sell
3,759
-100
-3% -$3.68K ﹤0.01% 1326
2023
Q3 		$148K Hold
3,859
– – ﹤0.01% 1390
2023
Q2 		$73.2K Buy
3,859
+270
+8% +$5.04K ﹤0.01% 1614
2023
Q1 		$56K Sell
3,589
-2,250
-39% -$39K ﹤0.01% 1683
2022
Q4 		$104K Buy
5,839
+39
+0.7% +$491 ﹤0.01% 1544
2022
Q3 		$59K Buy
5,800
+1,000
+21% +$4.89K ﹤0.01% 1684
2022
Q2 		$19K Buy
4,800
+4,400
+1,100% +$19K ﹤0.01% 2058
2022
Q1 		$2K Sell
400
-3,620
-90% -$22.5K ﹤0.01% 2342
2021
Q4 		$28K Sell
4,020
-2,880
-42% -$23.8K ﹤0.01% 1867
2021
Q3 		$60K Buy
6,900
+6,500
+1,625% +$58.6K ﹤0.01% 1892
2021
Q2 		$4K Hold
400
– – ﹤0.01% 2284
2021
Q1 		$6K Sell
400
-1,300
-76% -$34.3K ﹤0.01% 2250
2020
Q4 		$79K Buy
+1,700
New +$78.6K ﹤0.01% 1833

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nisa Investment Advisors's IMVT Position: Q2 2026 in Review

Nisa Investment Advisors increased its Immunovant (IMVT) stake by 5.6% in Q2 2026, buying an estimated $7.01K and bringing the position to 4,307 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Nisa Investment Advisors first reported a position in IMVT in Q4 2020 and has held it in 23 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Nisa Investment Advisors held 4,307 shares of Immunovant worth $166K as of Q2 2026.
  • Nisa Investment Advisors bought 230 Immunovant shares in Q2 2026, an estimated $7.01K.
  • Immunovant made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1320 holding.
  • Nisa Investment Advisors first reported a position in Immunovant in Q4 2020 and has held it in 23 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.